James Smith

3.8k total citations
49 papers, 1.4k citations indexed

About

James Smith is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, James Smith has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 13 papers in Infectious Diseases and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in James Smith's work include Influenza Virus Research Studies (15 papers), Respiratory viral infections research (6 papers) and HIV/AIDS Research and Interventions (4 papers). James Smith is often cited by papers focused on Influenza Virus Research Studies (15 papers), Respiratory viral infections research (6 papers) and HIV/AIDS Research and Interventions (4 papers). James Smith collaborates with scholars based in United Kingdom, United States and Switzerland. James Smith's co-authors include Regina Dutkowski, Penelope Ward, Ian Small, Craig R. Rayner, Stephen Toovey, B. E. Davies, Susan T. Sacks, V. S. Kitchen, Robert E. Ariano and Karl G. Nicholson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

James Smith

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Smith United Kingdom 21 794 278 275 143 134 49 1.4k
Alyson Smith United States 21 638 0.8× 339 1.2× 367 1.3× 89 0.6× 271 2.0× 47 1.4k
Frank Hanses Germany 24 536 0.7× 639 2.3× 231 0.8× 134 0.9× 181 1.4× 79 1.5k
Andrew J. H. Simpson United Kingdom 30 1.4k 1.8× 806 2.9× 406 1.5× 262 1.8× 227 1.7× 88 2.6k
Koichiro Kudo Japan 25 708 0.9× 684 2.5× 284 1.0× 187 1.3× 260 1.9× 138 2.2k
Toni Whistler United States 21 387 0.5× 212 0.8× 331 1.2× 103 0.7× 98 0.7× 62 1.4k
Agam K. Rao United States 23 507 0.6× 234 0.8× 505 1.8× 152 1.1× 51 0.4× 49 1.6k
Elena Pariani Italy 22 1.1k 1.4× 566 2.0× 327 1.2× 66 0.5× 182 1.4× 115 2.1k
Li Jin China 31 1.3k 1.6× 673 2.4× 365 1.3× 176 1.2× 283 2.1× 97 2.9k
Silvana K. Rampini Switzerland 17 397 0.5× 408 1.5× 458 1.7× 111 0.8× 219 1.6× 56 1.4k
Junjun Jiang China 21 538 0.7× 584 2.1× 259 0.9× 135 0.9× 80 0.6× 111 1.4k

Countries citing papers authored by James Smith

Since Specialization
Citations

This map shows the geographic impact of James Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Smith more than expected).

Fields of papers citing papers by James Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Smith. The network helps show where James Smith may publish in the future.

Co-authorship network of co-authors of James Smith

This figure shows the co-authorship network connecting the top 25 collaborators of James Smith. A scholar is included among the top collaborators of James Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Smith. James Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clinch, Barry & James Smith. (2015). Roche perspectives on Tamiflu. Clinical Microbiology and Infection. 21(3). 226–229. 3 indexed citations
2.
Smith, James, et al.. (2013). Contemporary Uses of Erythropoietin in Pregnancy. Obstetrical & Gynecological Survey. 68(8). 594–602. 32 indexed citations
3.
Tell, Richard A., G. Sias, James Smith, Jack D. Sahl, & Robert Kavet. (2012). ELF magnetic fields in electric and gasoline‐powered vehicles. Bioelectromagnetics. 34(2). 156–161. 18 indexed citations
4.
Smith, James, et al.. (2011). Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience. Advances in Therapy. 28(11). 927–959. 44 indexed citations
5.
Smith, James, Robert E. Ariano, & Stephen Toovey. (2010). The use of antiviral agents for the management of severe influenza. Critical Care Medicine. 38(4 Suppl). e43–e51. 46 indexed citations
6.
Smith, James. (2010). Oseltamivir in human avian influenza infection. Journal of Antimicrobial Chemotherapy. 65(Supplement 2). ii25–ii33. 27 indexed citations
7.
Ramsay, Colin N., James Smith, G. Hawkins, et al.. (2010). An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. Eurosurveillance. 15(2). 53 indexed citations
8.
Dutkowski, Regina, James Smith, & B. E. Davies. (2010). Safety and pharmacokinetics of oseltamivir at standard and high dosages. International Journal of Antimicrobial Agents. 35(5). 461–467. 52 indexed citations
9.
Smith, James & Susan T. Sacks. (2009). Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment. International Journal of Clinical Practice. 63(4). 596–605. 33 indexed citations
10.
Stephenson, Iain, Jane Democratis, Angie Lackenby, et al.. (2009). Neuraminidase Inhibitor Resistance after Oseltamivir Treatment of Acute Influenza A and B in Children. Clinical Infectious Diseases. 48(4). 389–396. 136 indexed citations
11.
Smith, James, et al.. (2008). Investigation of an HIV transmission cluster centred in South Wales. Sexually Transmitted Infections. 84(5). 377–380. 6 indexed citations
12.
Morrison, Dennis, Sandip Kumar Roy, Craig R. Rayner, et al.. (2007). A Randomized, Crossover Study to Evaluate the Pharmacokinetics of Amantadine and Oseltamivir Administered Alone and in Combination. PLoS ONE. 2(12). e1305–e1305. 49 indexed citations
13.
Smith, James, et al.. (2006). Aflatoxicosis in dogs and dealing with suspected contaminated commercial foods-Timely topics in nutrition. Journal of the American Veterinary Medical Association. 228. 2 indexed citations
14.
Brewster, Mike, James Smith, Regina Dutkowski, & Richard A. Robson. (2006). Active metabolite from Tamiflu® solution is bioequivalent to that from capsule delivery in healthy volunteers: A cross-over, randomised, open-label study. Vaccine. 24(44-46). 6660–6663. 12 indexed citations
15.
Ward, Penelope, et al.. (2005). Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic. Journal of Antimicrobial Chemotherapy. 55(suppl_1). i5–i21. 349 indexed citations
16.
Smith, James, Alana M. Thackray, & Raymond Bujdoso. (2001). Reduced herpes simplex virus type 1 latency in Flt‐3 ligand‐treated mice is associated with enhanced numbers of natural killer and dendritic cells. Immunology. 102(3). 352–358. 30 indexed citations
17.
Smith, James, G. Andersson, & C.W. Taylor. (1996). Annotated bibliography on power system stability controls: 1986-1994. IEEE Transactions on Power Systems. 11(2). 794–800. 13 indexed citations
18.
Smith, James, et al.. (1995). Advanced electrical architecture vehicle development. Automotive engineering. 103(2). 3 indexed citations
19.
Smith, James, et al.. (1991). Infertility management in HIV positive couples: a dilemma.. BMJ. 302(6790). 1447–1450. 20 indexed citations
20.
Smith, James, et al.. (1989). Replicated Factor Structure of the Beck Depression Inventory. The Journal of Nervous and Mental Disease. 177(8). 473–479. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alyson Smith Breakdown of academic impact, for papers by Frank Hanses Breakdown of academic impact, for papers by Andrew J. H. Simpson Breakdown of academic impact, for papers by Koichiro Kudo Breakdown of academic impact, for papers by Toni Whistler Breakdown of academic impact, for papers by Agam K. Rao Breakdown of academic impact, for papers by Elena Pariani Breakdown of academic impact, for papers by Li Jin Breakdown of academic impact, for papers by Silvana K. Rampini Breakdown of academic impact, for papers by Junjun Jiang
Rankless by CCL
2026